Association between new onset diabetic retinopathy and monocyte chemoattractant protein-1 (MCP-1) polymorphism in Japanese type 2 diabetes
- 1 June 2015
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 108 (3) , e35-e37
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetesGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetesDiabetes Research and Clinical Practice, 2010
- Monocyte chemoattractant protein-1: A key mediator in inflammatory processesThe International Journal of Biochemistry & Cell Biology, 2009
- Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosisProceedings of the National Academy of Sciences, 2007
- Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathyDiabetes Research and Clinical Practice, 2006
- Monocyte chemoattractant protein-1–induced angiogenesis is mediated by vascular endothelial growth factor-ABlood, 2005
- Upregulation of Chemokine Expression in the Retinal Vasculature in Ischemia-Reperfusion InjuryInvestigative Ophthalmology & Visual Science, 2003
- High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cellsBiochemical and Biophysical Research Communications, 2003
- Role of MCP-1 and MIP-1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularizationJournal of Leukocyte Biology, 2003
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999